Navigating the economic challenges in childhood cancer control in low- and middle-income countries: Insights from the CC-BRIDGE tool and the global initiative for childhood cancer.

The increasing incidence of childhood cancer in low- and middle-income countries (LMICs) presents significant economic and logistical challenges, affecting health care provision and equitable treatment access. This editorial explores the economic barriers to pediatric oncology care in LMICs, highlighting resource scarcity, socioeconomic inequities, and health care complexities. It emphasizes the need for detailed cost analysis within health systems complicated by inadequate data and variable treatment protocols. Central to the discussion is the "Childhood Cancers Budgeting Rapidly to Incorporate Disadvantaged Groups for Equity (CC-BRIDGE) Tool" from the manuscript by Nancy Bolous et al., who proposed an innovative method to estimate the cost of integrating childhood cancer services into National Cancer Control Plans. This tool aligns with the World Health Organization's Global Initiative for Childhood Cancer to enhance survival rates and advocate for universal health coverage in pediatric oncology. The CC-BRIDGE tool's methodological rigor provides a structured framework for cost analysis. Yet, it is recognized as an initial step requiring further enhancements for comprehensive economic forecasting and societal cost assessments. In conclusion, the editorial highlights the tool's critical role in incorporating childhood cancer care into national strategies in LMICs, contributing to the broader fight against cancer and advocating for comprehensive, equitable health care. It signifies a vital stride toward addressing pediatric oncology's economic challenges and supporting universal health coverage for childhood cancer care.

Development and psychometric validation of the Colorectal Cancer Literacy Scale-Uruguay Version.

Colorectal cancer is a leading cause of cancer death in Uruguay, yet less than half of the eligible population is up to date with screenings. Research is hampered because no measures exist to assess psychosocial factors that influence screening decisions in this population. To address this gap, we report on the development and psychometric validation of the Colorectal Cancer Literacy Scale-Uruguay Version, a scale based on the health literacy model. We developed an item pool based on the extant literature, obtained feedback from experts, and conducted focus groups with community participants and health care providers. After revision, we conducted a psychometric validation with a national community sample of 405 participants. Through an exploratory factor analysis, we identified four factors that were collapsed into two for theoretical and pragmatic reasons, representing (a) disposition toward cancer prevention and (b) attitudes, beliefs, and emotions about cancer. A third factor, knowledge about colorectal cancer, was examined separately given its distinct focus. Subsequently, we conducted a confirmatory factor analysis with the remaining sample participants using Rasch measurement theory for validation purposes and to further assess the scales' psychometric properties. The resulting 44-item scale presented a good model fit with adequate EAP reliabilities and good initial discriminant validity. Further criterion-related validity analyses should be performed when additional measures are available. The Colorectal Cancer Literacy Scale-Uruguay Version is a theoretically based measure that can bring to light barriers and facilitative factors in an underscreened population at risk. Implications for theory, research, and practice are discussed.

History of the National Cancer Registry of Panama.

Background: The National Cancer Registry of Panama (NCRP) was established in 1974. In 1984, histological confirmation became mandatory. The now pathology-based registry has evolved and has been a population-based cancer registry (PBCR) since 2012 with cancer-specific Web-based reporting software. Herein, we characterize the main features in its development that may help readers understand its evolution and improvements that are needed to be in line with international standards. Methods: We describe the major components of the NCRP using its structure, processes, and a results framework for 3 major periods since its inception: 1974-1999, 2000-2011, and 2012 to present. Results: The NCRP has always been linked to the Ministry of Health of Panama. Until the end of its second period, it operated as a pathology-based registry and all staff worked part time. Currently, the NCRP is based on passive reporting through a Web-based system set up for both public and private health institutions, covering 77% of the existing health-care institutions in the nation. The number of cases with unknown age were less than 10 per year and primary tumors with unknown origin were at most 3%. The proportion of death certificate only (DCO) cases decreased 5% in 18 years. Men are more likely to have DCO than women (odds ratio, 1.53; 95% CI, 1.48-1.58). Discussion: The NCRP has evolved, achieving significant improvements and progress over the years. Yet, much remains to be done. To provide internationally comparable, valid, and timely cancer incidence data, the NCRP should continue to improve its quality and coverage and provide continuous staff training on cancer registry procedures.

International burden of cancer deaths and years of life lost from cancer attributable to four major risk factors: a population-based study in Brazil, Russia, India, China, South Africa, the United Kingdom, and United States.

Background: We provide a comprehensive view of the impact of alcohol consumption, tobacco smoking, excess body weight, and human papillomavirus (HPV) infection on cancer mortality and years of life lost (YLLs) in Brazil, Russia, India, China, South Africa, the United Kingdom (UK), and United States (US). Methods: We collected population attributable fractions of the four risk factors from global population-based studies and applied these to estimates of cancer deaths in 2020 to obtain potentially preventable cancer deaths and their 95% confidence intervals (CIs). Using life tables, we calculated the number and age-standardised rates of YLLs (ASYR). Findings: In Brazil, Russia, India, China, South Africa, the UK, and the US in 2020, an estimated 5.9 million (3.3 million-8.6 million) YLLs from cancer were attributable to alcohol consumption, 20.8 million (17.0 million-24.6 million) YLLs to tobacco smoking, 3.1 million (2.4 million-3.8 million) YLLs to excess body weight, and 4.0 million (3.9 million-4.2 million) YLLs to HPV infection. The ASYR from cancer due to alcohol consumption was highest in China (351.4 YLLs per 100,000 population [95% CI 194.5-519.2]) and lowest in the US (113.5 [69.6-157.1]) and India (115.4 [49.7-172.7). For tobacco smoking, China (1159.9 [950.6-1361.8]) had the highest ASYR followed by Russia (996.8 [831.0-1154.5). For excess body weight, Russia and the US had the highest ASYRs (385.1 [280.6-481.2] and 369.4 [299.6-433.6], respectively). The highest ASYR due to HPV infection was in South Africa (457.1 [453.3-462.6]). ASYRs for alcohol consumption and tobacco smoking were higher among men than women, whereas women had higher ASYRs for excess body weight and HPV infection. Interpretation: Our findings demonstrate the importance of cancer control efforts to reduce the burden of cancer death and YLLs due to modifiable cancer risk factors and promote the use of YLLs to summarise disease burden. Funding: Cancer Research UK.

Methods and implementation of a Hospital-Based Cancer Registry in a major city in a low-to middle-income country: the case of Cali, Colombia.

PURPOSE: To describe our experience upon developing and implementing a hospital-based cancer registry (HBCR) in a quaternary-level of care private non-profit academic medical center in Cali, Colombia. METHODS: HBCRs capture, in a given institution, every single patient with a confirmed malignancy. In this study, all cases evaluated between 2014 and 2018 were included in the HBCR. In compliance with the International Agency for Research on Cancer recommendations, cases were classified as analytic or non-analytic. Data derived from an exhaustive selection of patients was stored in a computing platform owned by the institution, meeting the 2016 Facility Oncology Registry Data Standards recommendations. Quality control was performed by evaluating comparability, timeliness, validity, and completeness. RESULTS: A total of 24,405 new cases were registered between 2014 and 2018, from which 4253 (17.4%) died. Among all cases, based on the anatomic location, most common malignancies were breast (n = 1554), thyroid (n = 1346), hematolymphoid (n = 1251), prostatic (n = 805), and colorectal (n = 624). The behavior of the new cases was consistent with an incremental trend. CONCLUSION: Upon implementing the HBCR, major challenges were identified (i.e., a precise definition of cases, the development of processes for capturing new cases, a standardized data collection strategy, and carrying-out an appropriate patient follow-up). Based on our experience, the success of an HBCR largely relies on the interest from the institution, the engagement of stakeholders and financial support, that is, it depends on the adequate access over time to funding, technological, and staffing resources.

Vacunas basadas en neoantígenos y control del cáncer: perspectivas / Neoantigen vaccines and cancer control: perspectives

Resumen La supervivencia global y la calidad de vida son objetivos primarios del tratamiento del cáncer. El desarrollo de terapias blanco promovió el concepto de tratamientos personalizados, los que se han evaluado principalmente mediante desenlaces centrados en el tumor y han tenido foco en tumores de baja frecuencia y estados avanzados. La inmunoterapia rompe esta tendencia y genera expectativa por su efecto en la supervivencia global y su potencial uso en una gama amplia de tumores. Dentro de esta, las vacunas basadas en neoantígenos han mostrado alta eficacia y seguridad debido a su afinidad con células T y su elevada especificidad. Basado en sus principios biológicos se revisa su posible impacto en la carga de enfermedad según la relación entre potencial inmunogénico y prevalencia por tipo de tumor, el posible efecto en la práctica clínica por su combinación con otras modalidades de tratamiento, y el efecto en el acceso al tratamiento dado su proceso de desarrollo y producción y la disponibilidad de información propia.

Abstract Overall survival and quality of life are primary goals of cancer treatment. The recent development of targeted therapies has fostered the concept of personalized treatments, which have been evaluated mainly through tumor-centered outcomes and have focused on low-prevalence tumors and advanced stages. Immunotherapy halts this trend and generates expectation regarding its impact on overall survival and its potential use in a wide range of tumors. As part of immunotherapy, neoantigen vaccines have shown high efficacy and safety due to their affinity with T cells and their high specificity. Based on biological principles, we reviewed their potential impact on the burden of disease given the immunogenicity and prevalence by tumor type, the possible effect on clinical practice due to their combination with other treatment modalities, and the effect on access to treatment, given the process of development and production and the availability of local data.

Health system strengthening: Integration of breast cancer care for improved outcomes.

The adoption of the goal of universal health coverage and the growing burden of cancer in low- and middle-income countries makes it important to consider how to provide cancer care. Specific interventions can strengthen health systems while providing cancer care within a resource-stratified perspective (similar to the World Health Organization-tiered approach). Four specific topics are discussed: essential medicines/essential diagnostics lists; national cancer plans; provision of affordable essential public services (either at no cost to users or through national health insurance); and finally, how a nascent breast cancer program can build on existing programs. A case study of Zambia (a country with a core level of resources for cancer care, using the Breast Health Global Initiative typology) shows how a breast cancer program was built on a cervical cancer program, which in turn had evolved from the HIV/AIDS program. A case study of Brazil (which has enhanced resources for cancer care) describes how access to breast cancer care evolved as universal health coverage expanded. A case study of Uruguay shows how breast cancer outcomes improved as the country shifted from a largely private system to a single-payer national health insurance system in the transition to becoming a country with maximal resources for cancer care. The final case study describes an exciting initiative, the City Cancer Challenge, and how that may lead to improved cancer services.

Back and forth between cancer treatment and cancer control programs: Insights from the Cuban experience.

Cancer control is a wider concept than oncology, and includes comprehensive actions for prevention, early diagnosis, treatment, services organization, and education, aiming to modify hard indicators such as incidence, mortality rates, and survival at a population scale. Based on these concepts, organized national cancer programs appeared in several countries in the second half of the 20th century. But at the same time, scientific efforts began to modify the landscape of cancer control. Evidence of mortality reductions began to appear, cancer-driving mutations became measurable, many novel drugs were registered, the methodology of clinical trials spread through health systems, targeted drugs and immunotherapy entered into the mainstream of therapeutics, and treatment goals started to shift from cure to chronic control. The implementation and impact of organized interventions for cancer control show variations according to the context of diverse countries, and scientists and health decision makers can learn from studying these diverse experiences. Among the salient features of cancer control in Cuba are the simultaneous development of a primary care network with abundant human resources and a national biotechnology industry with capacity to provide both generic and innovating drugs and diagnostic systems. The program intentionally assumes the goal of accelerating the transformation of advanced cancer into a chronic disease susceptible of long-term control. The implications of this strategy for population interventions and for scientific research are discussed.

A pharmacoeconomic analysis of the collection and preservation of samples in the biobank of the "Instituto Nacional de Cancerología" in Mexico City.

In this work we estimated the budgetary impact of the samples produced by the biobank of the "Instituto Nacional de Cancerología" (BT-INCan) to set a recuperation fee from the perspective of the Health Ministry of Mexico. The study is an observational retrospective review of the direct medical costs (DMCs) of the processes involved in cryopreservation of the samples collected, on a per sample basis, including materials, laboratory tests, personnel, and administrative costs. Materials and labor costs were determined by information collected from the BT-INCan. DMCs were provided depending on the type of sample: plasma, tissue and biopsy; they were calculated according to the process required to preserve them. Sensitivity analysis was performed using bootstrap. Recuperation costs ranged from 130 to 155 USD. Costs were considered on a 5-year time frame for the maintenance per sample, which is the average time that a sample is kept in the BT-INCan. The cost analysis is perceived as an approximation to the most adequate recuperation fee per sample needed to guarantee the correct development of the BT-INCan. This work provides a basis and valuable information about costs, to enable several health institutions to strategically plan and manage a biobank or even motivate to establish their own biobank.

Papel de la interculturalidad en el control del cáncer en pueblos indígenas

Pese a su importancia, la población indígena se caracteriza por tener mayor pobreza, menor acceso a educación y a salud, lo que conlleva a reducir su expectativa de vida. Otros aspectos como el elevado nivel de desempleo, la precariedad de servicios sociales, la vulneración de Derechos Humanos y la degradación del ambiente, configuran un desfavorable escenario de discriminación, marginación y exclusión. Aunque es bien conocida la necesidad de ofrecer servicios de salud diferenciales, esto aún no logra materializarse, lo que sumado a la ausencia de información y estrategias apropiadas, lleva a la falta de goce efectivo de la población indígena de los servicios para el control del cáncer que son accesibles al resto de la población. Dado lo anterior, es indispensable la reflexión respecto al estado y papel de la interculturalidad en el control del cáncer.

Despite its importance, the indigenous population is characterized by greater poverty, less access to education and health services, which leads to reduced life expectancy. Other facts such as the high rate of unemployment, the precarious social services, the violation of Human Rights and the environment degradation, constitute an unfortunate scenario of discrimination, marginalization and exclusion. Although the need to offer differential health services is well known, this has not yet materialized, in addition, the lack of information and appropriate strategies, leads to indigenous population unable to enjoy effectively the cancer control services. which are accessible to the rest of the population. According to the above mentioned, it is essential to reflect on the condition and role of interculturality in cancer control.

Apesar de sua importância, a população indígena é caracterizada por maior pobreza, menor acesso à educação e à saúde, o que leva a uma redução da expectativa de vida. Outros aspectos, como o alto nível de desemprego, a precariedade dos serviços sociais, a violação dos direitos humanos e a degradação do meio ambiente, constituem um cenário desfavorável de discriminação, marginalização e exclusão. Embora a necessidade de oferecer serviços diferenciais de saúde seja bem conhecida, isso ainda não é uma realidade, o que, somado à falta de informações e estratégias adequadas, leva à falta de aproveitamento efetivo dos serviços de controle de câncer por parte da população indígena, embora tais serviços são acessíveis para o resto da população. Diante do exposto, é essencial refletir sobre o status e o papel da interculturalidade no controle do câncer.

Plan Control del cáncer en Colombia 2012-2021. Un análisis formal / Cancer Control Plan in Colombia 2012-2021. A Formal Analysis / Plano Controle do cancro na Colômbia 2012-2021. Análise formal

Resumen En Colombia el cáncer es un problema de salud pública. Su incidencia y mortalidad afectan tanto a la población adulta como a la población pediátrica. Desde el año 2010 el país se viene preparando para afrontar este problema. El Instituto Nacional de Cancerología (INC) ha realizado investigaciones para caracterizar epidemiológicamente el cáncer, así como otros factores que inciden en su letalidad. Las leyes 1384 y 1388 de 2010 fijaron las bases para el control integral del cáncer y designaron al INC para asesorar al Ministerio de Salud y Protección Social en esta tarea. Se analizó el contenido del plan, con base en una guía elaborada por la Facultad de Salud Pública de la Universidad de Antioquia. Debido a la importancia del problema y la complejidad de la política, se concluye: solo con un sistema estricto de monitoreo, una evaluación permanente de las actividades del plan y la aplicación de correctivos oportunos, Colombia podría alcanzar las metas en el control del cáncer.

Abstract In Colombia, cancer is a public health problem. Its incidence and mortality affects both adult and pediatric population. Since 2010 the country has been preparing to address this problem. The National Cancer Institute (NCI) has conducted research to characterize epidemiologically cancer as well as other factors that influence their lethality. 1384 and 1388 laws of 2010 laid the foundation for comprehensive cancer control and designated the INC to advise the Ministry of Health and Social Protection in this task. We analyzed the contents of the plan, based on a guide developed by the School of Public Health at the University of Antioquia. Because of the importance of the problem and the complexity of the policy concludes: Only a strict monitoring system, continuous evaluation and timely corrective plan of activities, Colombia could reach targets in cancer control.

Resumo Na Colômbia, o câncer é um problema de saúde pública. A incidência e a mortalidade afectar ambos os adultos e a população pediátrica. Desde 2010 o país tem vindo a preparar para resolver este problema. O Instituto Nacional do Câncer (INC) realizou uma pesquisa para caracterizar epidemiologicamente câncer, bem como outros fatores que influenciam sua letalidade. 1384 e 1388 leis de 2010 lançou as bases para o controle integral de câncer eo INC nomeado para assessorar o Ministério da Saúde e Protecção Social nesta tarefa. o conteúdo do plano foi analisado, com base em um guia desenvolvido pela Escola de Saúde Pública da Universidade de Antioquia. Devido à importância do problema e da complexidade da política, ele conclui: Colômbia poderia atingir as metas para o controle do câncer se aplicado rigoroso sistema de monitorização, uma avaliação contínua das actividades do plano ea implementação de medidas corretivas adequadas.

Outcomes of treatment in men with prostate cancer at the cancer centre Bahamas.

PURPOSE: This is a first report from The Bahamas of management and long-term outcomes in men with non-metastatic prostate cancer treated with radiotherapy, with or without androgen deprivation therapy, from 2004 to 2016. METHODS: Patients were characterized by baseline factors, stratified by risk groups using tumor stage (clinical T-stage), prostate-specific antigen (PSA) test result and Gleason grade, and sorted by treatment combinations (by radiation volume and use of androgen deprivation). RESULTS: Overall, 205/216 men were Afro-Caribbean. Median age was 66. There were 18 low-, 77 intermediate-, and 121 high-risk patients, treated with prostate-only versus pelvis plus prostate radiotherapy, many receiving 2 years of androgen suppression. Time to commence radiation was about 6 months from initial diagnosis. In those not relapsing, global PSA nadir was reached in 4 years and was under 1.0, reduced from a mean at baseline of 31. At 10 years, disease-free experience (32 relapses) was 68% and overall survival was 87%, although only 2/12 deaths were related to prostate cancer. This experience compares favorably with recently published outcomes from other countries using very similar treatments. CONCLUSIONS: This study establishes benchmark statistics from diagnosis to long-term follow-up. Outcomes in Bahamian men are consistent with expectations from risk-stratified guidelines followed in developed countries.

Cancer Genomic Resources and Present Needs in the Latin American Region.

In Latin America (LA), cancer is the second leading cause of death, and little is known about the capacities and needs for the development of research in the field of cancer genomics. In order to evaluate the current capacity for and development of cancer genomics in LA, we collected the available information on genomics, including the number of next-generation sequencing (NGS) platforms, the number of cancer research institutions and research groups, publications in the last 10 years, educational programs, and related national cancer control policies. Currently, there are 221 NGS platforms and 118 research groups in LA developing cancer genomics projects. A total of 272 articles in the field of cancer genetics/genomics were published by authors affiliated to Latin American institutions. Educational programs in genomics are scarce, almost exclusive of graduate programs, and only few are concerning cancer. Only 14 countries have national cancer control plans, but all of them consider secondary prevention strategies for early diagnosis, opportune treatment, and decreasing mortality, where genomic analyses could be implemented. Despite recent advances in introducing knowledge about cancer genomics and its application to LA, the region lacks development of integrated genomic research projects, improved use of NGS platforms, implementation of associated educational programs, and health policies that could have an impact on cancer care.

Control of cervical cancer in Peru: Current barriers and challenges for the future.

Cervical cancer is the leading malignant neoplasm in Peruvian women. This malignancy is a public health problem and several efforts were previously performed to develop cancer control plans. Geographical, cultural, structural, infrastructural and procedural barriers can limit the implementation of such strategies. Several previous studies have characterized human papilloma virus (HPV) epidemiology, where prevalence of high-risk HPV in adult females is ~12% and the prevalence in cervical cancer is 90-95%. The predominant barriers for the control of cervical cancer are lack of specialists in remote villages, education/cultural issues, loss of patients in follow-up, lack of access to HPV testing and lack of compliance for HPV vaccination. A good strategy for the prevention and early detection of high-risk HPV, pre-malignant neoplasms and cervical cancer, identified by interventional studies, is the self-sampling test, which assists with overcoming the cultural and geographic barriers. The current cancer control plan, termed 'Plan Esperanza', is performed with massive training of health professionals and social sensitization campaigns leading to filling the gaps regarding education and, in addition, it provides cancer care coverage for poorer individuals. In our experience at Oncosalud-AUNA, with a cohort of ~750,000 affiliates using a pre-paid system with annual screenings for cervical cancer for women, offered free-of-charge, a lower incidence of this malignancy (5.8/100,000) is now observed compared with the national incidence (32.7/100,000). As in other countries, the HPV vaccination can be a cost-utility strategy to reduce the high burdens of cervical cancer in Peru, a rapid and cheap HPV molecular sub-typification is rapidly required.

Evaluation of hela cell lineage response to β radiation from Holmium-166 embedded in ceramic seeds

This work studied the effects of β radiation of Ho-166 embedded in ceramic seeds on HeLa cells. Methodology consisted in the production of ceramic seeds with holmium-165 by sol-gel route. Chemical and physical characterizations of the seeds were performed. Subsequently, nuclear characterization was performed by gamma spectrometry. Experimental and theoretical activities were defined and initial dose rate were evaluated by MIRD (Medical Internal Radiation Dose Committee) methodology. The seeds were placed in confluent culture flasks and remained for six radionuclide half-lives. Biological results were represented by a clean 6 mm diameter area around the seed where the tumour cells were killed. The initial dose rate was 15.5 Gy. h-1. The maximum absorbed dose was 591.3 Gy. The features of the Ho-166 seeds suggested that such ceramic seeds were suitable for high dose rate brachytherapy.

As campanhas educativas contra o câncer / Cancer education campaigns

Discute a trajetória das campanhas educativas contra o câncer, seu papel na política de controle da doença e sua evolução entre 1920 e 1950. Através das imagens pode-se perceber a permanência de conceitos do campo da cancerologia surgidos no início do século XX. Diagnóstico precoce e tratamento médico especializado formavam o binômio que embasava os argumentos médicos sobre a alta possibilidade de cura da doença. A esses termos somava-se uma noção de prevenção que preconizava: evitar as causas externas de irritação dos tecidos seria a principal forma de proteção. Embora a estética dessas campanhas se tenha transformado ao longo dos anos, buscando atrair o público e chamar sua atenção para os perigos da doença, a base de sua concepção permaneceu a mesma.

The article explores the history of cancer education campaigns, their role in disease control policies, and the changes they underwent between 1920 and 1950. Through images, we see how concepts that arose in the early twentieth century have persisted in the field of cancerology. Medical arguments about the great likelihood of curing the disease were grounded on two things: early diagnosis and specialized medical treatment. The notion of prevention also figured in, with the main form of protection believed to be avoidance of any external cause of tissue irritation. Although the aesthetics of these campaigns has shifted over time, including efforts to attract the public and call their attention to the dangers of the disease, their conceptual basis has remained the same.

O controle do câncer no Brasil na primeira metade do século XX / Cancer control in Brazil in the first half of the twentieth century

Discute as ações públicas para o controle do câncer no país, entre a década de 1920 e o final dos anos 1940. Trata da criação da Inspetoria de Profilaxia da Lepra e das Doenças Venéreas, no âmbito do Departamento Nacional de Saúde Pública, primeira ação pública relacionada à doença. Embora de pouco alcance, seu surgimento permite a compreensão do campo profissional, relacionado à doença, existente à época. Observa o papel da difusão da eletrocirurgia na ampliação do interesse médico pelo câncer e na criação do Centro de Cancerologia do Distrito Federal. Discute a criação e a primeira década de atuação do Serviço Nacional de Câncer, aproximando seu perfil inicial das questões que nortearam sua trajetória.

The article discusses public efforts to control cancer in Brazil from the 1920s to the close of the 1940s. It examines the process which brought about creation of the Inspectorship to Combat Leprosy, Venereal Diseases, and Cancer within the National Department of Public Health. Creation of the Inspectorship was the first public action to target cancer and, while it was not far-reaching, its emergence enables us to understand the professional field of cancer at that time. The text also points to the role played by the diffusion of electrosurgery in expanding medical interest about cancer and in the founding of the Cancerology Center in the Federal District. It discusses the establishment and first decade of activities of the National Cancer Service, endeavoring to link the Service's initial profile with the issues that guided its history.